本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/11/141 分钟阅读
CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List
本地自动翻译 · 来源原始语言
摘要
SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…
来源原始语言: PR Newswire — Global News Releases打开原始公告 →